提高儿科急诊抗菌药物管理挑战的AWaRe意识:PERFORM研究评估欧洲抗生素处方一致性与适当性的结果
PERFORM研究纳入2016年8月至2019年12月欧洲9国急诊发热疑似感染患儿,按最终细菌或病毒表型分析经验性全身抗生素使用。2130例中细菌表型1549例(72.7%),病毒表型581例(27.3%);细菌组85.1%和病毒组46.3%接受了经验性全身抗生素,病毒组中80.3%使用了至少1种WHO Watch类抗生素。结论认为急诊初始区分细菌与病毒病因仍具挑战,导致大量抗生素过度处方。
要点
- 细菌表型患儿中85.1%接受了经验性全身抗生素,病毒表型患儿中46.3%也接受了经验性全身抗生素。
- 接受经验性全身抗生素的病毒表型患儿中,80.3%使用了至少1种WHO Watch类抗生素。
- 急诊快速准确的病原学即时检测可能显著改善抗菌药物管理。
核心结论
- 急诊初始区分发热病因的细菌与病毒属性仍具挑战,导致大量抗生素过度处方。
- 相当比例的病毒表型患者接受了全身抗生素,主要为WHO Watch类。
- 急诊快速准确区分细菌与病毒病因的即时检测可能显著改善抗菌药物管理。
研究设计与样本
- PERFORM(Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management)研究,2016年8月至2019年12月在欧洲9国急诊招募疑似感染的发热患儿。
- 排除非细菌/非病毒表型患儿后,共分析2130例发热事件,按最终分配的「细菌」或「病毒」表型评估经验性全身抗生素使用。
- 抗生素按世界卫生组织(WHO)AWaRe分类法分类。
主要发现
- 2130例发热事件中,1549例(72.7%)为细菌表型,581例(27.3%)为病毒表型。
- 细菌表型中1318/1549例(85.1%)和病毒表型中269/581例(46.3%)在入院前2天内接受了经验性全身抗生素。
- 接受经验性全身抗生素者中,细菌组87.8%和病毒组87.0%使用了肠外抗生素。
- 最常处方的3类抗生素为第三代头孢菌素、青霉素类和青霉素/β-内酰胺酶抑制剂复方。
- 病毒组接受经验性全身抗生素者中,216/269例(80.3%)使用了至少1种「Watch」类抗生素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Optimization of antimicrobial stewardship is key to tackling antimicrobial resistance, which is exacerbated by overprescription of antibiotics in pediatric emergency departments (EDs). We described patterns of empiric antibiotic use in European EDs and characterized appropriateness and consistency of prescribing. METHODS: Between August 2016 and December 2019, febrile children attending EDs in 9 European countries with suspected infection were recruited into the PERFORM (Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management) study. Empiric systemic antibiotic use was determined in view of assigned final "bacterial" or "viral" phenotype. Antibiotics were classified according to the World Health Organization (WHO) AWaRe classification. RESULTS: Of 2130 febrile episodes (excluding children with nonbacterial/nonviral phenotypes), 1549 (72.7%) were assigned a bacterial and 581 (27.3%) a viral phenotype. A total of 1318 of 1549 episodes (85.1%) with a bacterial and 269 of 581 (46.3%) with a viral phenotype received empiric systemic antibiotics (in the first 2 days of admission). Of those, the majority (87.8% in the bacterial and 87.0% in the viral group) received parenteral antibiotics. The top 3 antibiotics prescribed were third-generation cephalosporins, penicillins, and penicillin/β-lactamase inhibitor combinations. Of those treated with empiric systemic antibiotics in the viral group, 216 of 269 (80.3%) received ≥1 antibiotic in the "Watch" category. CONCLUSIONS: Differentiating bacterial from viral etiology in febrile illness on initial ED presentation remains challenging, resulting in a substantial overprescription of antibiotics. A significant proportion of patients with a viral phenotype received systemic antibiotics, predominantly classified as WHO Watch. Rapid and accurate point-of-care tests in the ED differentiating between bacterial and viral etiology could significantly improve antimicrobial stewardship.
引用
- Kolberg L, Khanijau A, van der Velden FJS, et al. Raising AWaRe-ness of Antimicrobial Stewardship Challenges in Pediatric Emergency Care: Results from the PERFORM Study Assessing Consistency and Appropriateness of Antibiotic Prescribing Across Europe. Clin Infect Dis. 2024. PMID: 37820031. doi:10.1093/cid/ciad615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。